Stryker Corporation $SYK Stock Bought by Consolidated Investment Group LLC

Consolidated Investment Group LLC boosted its stake in Stryker Corporation (NYSE:SYK) by 40.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,530 shares of the medical technology company’s stock after purchasing an additional 6,500 shares during the period. Consolidated Investment Group LLC’s holdings in Stryker were worth $6,205,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of SYK. Community Bank & Trust Waco Texas lifted its holdings in Stryker by 2.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock worth $439,000 after buying an additional 31 shares during the period. Cornerstone Financial Management LLC increased its stake in shares of Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after buying an additional 31 shares during the period. NWF Advisory Services Inc. increased its stake in shares of Stryker by 2.3% in the second quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company’s stock valued at $463,000 after buying an additional 33 shares during the period. Private Harbour Investment Management & Counsel LLC increased its stake in shares of Stryker by 0.9% in the second quarter. Private Harbour Investment Management & Counsel LLC now owns 3,927 shares of the medical technology company’s stock valued at $1,236,000 after buying an additional 34 shares during the period. Finally, Natural Investments LLC raised its position in shares of Stryker by 1.2% during the second quarter. Natural Investments LLC now owns 2,789 shares of the medical technology company’s stock worth $878,000 after acquiring an additional 34 shares during the last quarter. 77.09% of the stock is owned by institutional investors.

Stryker Stock Down 0.1%

Shares of NYSE:SYK opened at $325.69 on Tuesday. The company has a market capitalization of $123.99 billion, a price-to-earnings ratio of 23.78, a P/E/G ratio of 2.33 and a beta of 0.78. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.18 and a quick ratio of 1.30. The business’s 50-day moving average is $292.26 and its 200-day moving average is $323.41. Stryker Corporation has a 1 year low of $267.00 and a 1 year high of $389.33.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 29th. The medical technology company reported $3.52 EPS for the quarter, missing the consensus estimate of $3.55 by ($0.03). The business had revenue of $6.52 billion for the quarter, compared to analyst estimates of $6.62 billion. Stryker had a return on equity of 23.74% and a net margin of 13.78%. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the prior year, the business earned $3.19 EPS. Equities research analysts predict that Stryker Corporation will post 14.84 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently commented on SYK. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a report on Saturday, October 3rd. TD Cowen decreased their target price on shares of Stryker from $298.00 to $290.00 and set a “hold” rating for the company in a research report on Friday, October 30th. Wolfe Research lowered shares of Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. Robert W. Baird dropped their price target on shares of Stryker from $385.00 to $334.00 in a research report on Friday, October 30th. Finally, Citigroup restated a “market outperform” rating on shares of Stryker in a research report on Friday, October 30th. Twenty-one analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and an average target price of $342.19.

Insiders Place Their Bets

In other news, insider Dylan Crotty sold 441 shares of Stryker stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Ronda E. Stryker sold 550,000 shares of Stryker stock in a transaction on Friday, November 6th. The shares were sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the completion of the sale, the director owned 1,701,375 shares of the company’s stock, valued at $553,491,315. This represents a 24.43% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 901,267 shares of company stock worth $297,123,701. Corporate insiders own 4.60% of the company’s stock.

About Stryker

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr.